TrialInternational journal of molecular sciences2024

Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study.

Nayoun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.